GHK-Cu
Copper peptide · Glycyl-L-histidyl-L-lysine:Cu(II)
Related Laboratory Supplies
Essential items for laboratory research and sample preparation.
Third-Party Tested
HPLC Purity & Mass Spec Identity
Batch-Specific COA
Certificate for Each Batch
Discreet Packaging
Plain, Unbranded & Tamper-Evident
Same-Day Dispatch
Order Before 2PM AEST, Australia-Wide
GHK-Cu is a copper-binding tripeptide studied for its involvement in cellular signalling, extracellular matrix regulation and tissue-related biological processes. The compound consists of glycyl-L-histidyl-L-lysine complexed with copper(II) ions. GHK-Cu Australia research covers areas including peptide–metal interactions, collagen-related pathways and cellular responses to oxidative stress. The material described here is intended strictly for laboratory and in-vitro research, not human or veterinary use.
What Is GHK-Cu?
GHK-Cu, also known as copper tripeptide-1, is a coordination complex formed when the naturally occurring tripeptide GHK binds a copper(II) ion. Its three amino acids are glycine, histidine and lysine.
GHK occurs naturally in biological systems and has been investigated for its ability to bind copper and participate in processes associated with tissue maintenance and cellular communication.
Researchers study GHK-Cu because copper availability and peptide interactions can influence enzyme activity, extracellular matrix components and cellular responses.
The compound has attracted particular interest in skin biology, connective tissue research and experimental models of cellular repair. These research findings do not establish the safety or suitability of independently supplied GHK-Cu laboratory material for therapeutic or cosmetic use.
GHK-Cu in Cellular and Tissue Research
GHK-Cu research covers several areas of cellular biology, particularly processes associated with connective tissue and extracellular matrix regulation.
Laboratory investigations have examined:
- Collagen and elastin-related cellular pathways.
- Fibroblast activity in controlled experimental models.
- Copper-dependent biochemical interactions.
- Oxidative stress-associated cellular responses.
- Gene expression and extracellular matrix regulation.
Some published studies report changes in biological markers associated with tissue remodelling. However, the findings vary according to the model, concentration, exposure conditions and methods used.
Results from cell-based experiments cannot automatically be extended to clinical outcomes or independently supplied research materials.
Quick Product Information
| Specification | Details |
|---|---|
| Product name | GHK-Cu (Copper Tripeptide-1) |
| Research classification | Copper-binding tripeptide complex |
| Research targets | Copper coordination, extracellular matrix signalling and cellular pathways |
| Molecular formula | C₁₄H₂₂CuN₆O₄ |
| Molecular weight | Approximately 401.91 g/mol |
| CAS number | 89030-95-5 |
| Physical form | Lyophilised powder, subject to product specification |
| Available strengths | 50 mg and 100 mg |
| Purity | Refer to verified batch-specific documentation |
| Analytical testing methods | HPLC and MS, where documented |
| Certificate of Analysis | Batch-specific CoA, where available |
| Storage requirements | Follow verified product and batch documentation |
| Intended use | Laboratory and in-vitro research only |
How GHK-Cu Works in Research
Copper Binding and Cellular Activity
GHK contains amino acid groups capable of coordinating copper(II) ions. This interaction forms the GHK-Cu complex, which is investigated for its chemical stability and potential influence on copper-associated biological processes.
Copper participates in several cellular functions, including enzyme activity and oxidative balance. Researchers examine how peptide-bound copper behaves under controlled experimental conditions.
Extracellular Matrix Signalling
GHK-Cu has been studied in experimental systems involving fibroblasts, collagen-related processes and extracellular matrix components.
Published studies have explored changes in cellular activity and matrix-associated markers following exposure to the compound.
These observations depend on experimental conditions, cell type and analytical methods. They should not be interpreted as evidence that research-grade GHK-Cu produces the same effects in humans.
GHK-Cu vs Other Research Peptides
GHK-Cu differs from other research peptides in its molecular structure and primary areas of investigation.
| Compound | Scientific classification | Research focus |
|---|---|---|
| GHK-Cu | Copper-binding tripeptide | Copper coordination and extracellular matrix signalling |
| BPC-157 | Synthetic pentadecapeptide | Experimental tissue-related signalling |
| TB-500 | Thymosin beta-4-related peptide fragment | Cell migration and cytoskeletal processes |
These compounds are chemically distinct and should not be considered interchangeable. Their published findings also arise from different experimental systems.
GHK-Cu Research in Australia
Australian laboratories working with GHK-Cu should maintain clear records of material identity, batch information and analytical documentation.
Research-only peptides are distinct from therapeutic products regulated by the Therapeutic Goods Administration (TGA). A research-use label does not itself establish regulatory exemption or authorise therapeutic supply.
Researchers should consider the intended application, applicable Australian regulatory requirements and institutional laboratory procedures.
Batch traceability is particularly important when comparing experimental findings, as differences in material composition or handling conditions may influence results.
Specifications
Certificate of Analysis
Quality, Purity and Batch Testing
Analytical testing helps laboratories assess the identity and composition of GHK-Cu research material.
High-Performance Liquid Chromatography (HPLC) can be used to examine chromatographic purity and identify detectable impurities. Mass Spectrometry (MS) supports molecular identity assessment through mass-related measurements.
A batch-specific Certificate of Analysis should identify the material, batch number, analytical methods, results and relevant acceptance criteria.
For copper peptide complexes, researchers should also consider whether testing adequately confirms the intended copper-associated form.
A reported purity percentage does not independently establish sterility, biological safety or suitability for human use.
Storage & Handling
Storage and Laboratory Handling
GHK-Cu should be stored according to the conditions specified in its verified product or batch documentation.
Laboratories should consider temperature control, moisture exposure, light sensitivity where applicable and the integrity of sealed containers.
Handling procedures should minimise contamination and maintain accurate sample identification.
Storage periods and conditions for prepared solutions should not be assumed without supporting stability data. Laboratory standard operating procedures should guide material handling and documentation.
Research Use Only: For Research Use Only. Not for human or veterinary use. This material is intended strictly for laboratory and in-vitro research purposes and must not be consumed or administered.
Reconstitution calculator: GHK-Cu 50mg
Work out concentration and the volume to draw for each aliquot before you add diluent.
- Concentration
- –
- Volume per aliquot
- –
- On a 1 mL (U-100) syringe
- –
- Aliquots per vial
- –
A laboratory arithmetic aid only. Verify every calculation independently. Not dosing guidance; research use only.
GHK-Cu Frequently Asked Questions
GHK-Cu is a copper-binding tripeptide complex made from glycine, histidine and lysine. It is studied for its interactions with copper ions and cellular processes associated with extracellular matrix regulation.
GHK-Cu is a metallopeptide complex consisting of a three-amino-acid peptide coordinated with copper(II). It differs from ordinary tripeptides because the copper ion forms part of its chemical structure.
GHK is the copper-free tripeptide, while GHK-Cu is its copper-associated complex. Copper binding changes the compound's chemical characteristics and is relevant to studies involving peptide–metal interactions.
Researchers investigate GHK-Cu in experimental skin models because of its reported interactions with fibroblasts, extracellular matrix components and collagen-associated signalling. These findings do not establish clinical effectiveness.
Yes. Published laboratory investigations have examined GHK-Cu in relation to collagen-associated cellular processes and extracellular matrix regulation. Results depend on the experimental model and testing conditions.
The neutral 1:1 copper complex is represented as C₁₄H₂₂CuN₆O₄, with a molecular weight of approximately 401.91 g/mol. Charged forms have different representations in chemical databases.
HPLC can assess chromatographic purity, while mass spectrometry helps examine molecular identity. Additional analytical methods may be necessary to characterise copper coordination and confirm the material's composition.
A CoA should identify the batch, compound, analytical methods, reported results and acceptance criteria. Supporting chromatograms or mass spectra may provide further information about identity and purity.
Storage should follow the verified batch documentation. Laboratories should control environmental exposure, protect container integrity and maintain appropriate records without assuming unsupported stability periods or prepared-solution shelf life.
No. The research material described here is intended for laboratory investigation only. It is not presented as a medicine, cosmetic preparation or material suitable for human or veterinary administration.
No. This product is supplied strictly for in-vitro laboratory research. It is not approved for human or veterinary use and must not be consumed or administered.
Orders placed before 2PM AEST on business days are dispatched the same day from Melbourne. Standard Post takes 3–7 business days and Express Post 1–3 business days, both tracked and discreet.



Reviews
There are no reviews yet.